GlassScriptPhysician profile
Sascha Qian
NPI 1801161914
$4,274.42
in general payments reported to CMS, 2019-2025
26 companies · $1,899 in 2025
The $1,899 reported for 2025 was more than what 81% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $71.41 · 2021: $29.17 · 2023: $220 · 2024: $1,328 · 2025: $1,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,176 · Travel and Lodging: $1,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,176.18 |
| Travel and Lodging | $1,270.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $835.00 | 2020-2025 | Proclaim, Infinity |
| Boston Scientific Corporation | $664.02 | 2019-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $522.19 | 2024-2025 | Inceptiv, V-Loc 180 |
| Curonix LLC | $327.56 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $235.82 | 2023-2025 | Belbuca, Xtampza |
| Nevro Corp. | $218.46 | 2019-2020 | |
| Abbvie INC. | $183.15 | 2023-2025 | |
| Mml US, INC. | $179.50 | 2025 | Reactiv8 |
| Vertos Medical, INC. | $141.96 | 2024 | Mild Device Kit |
| Globus Medical, INC. | $135.93 | 2025 | Senza, Vyrsa V1 |
| Pfizer INC. | $132.51 | 2023-2024 | |
| Akcea Therapeutics, INC. | $125.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $116.97 | 2024-2025 | |
| Averitas Pharma INC. | $87.32 | 2023-2025 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.02 | 2019-2025 | Relistor |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $62.60 | 2019 | |
| Stryker Corporation | $43.79 | 2023 | Spinejack |
| Mallinckrodt Hospital Products INC. | $38.56 | 2024 | Acthar |
| Merz Pharmaceuticals, LLC | $30.62 | 2024-2025 | Xeomin |
| Scilex Pharmaceuticals INC. | $24.79 | 2019 | |
| Relievant Medsystems, INC. | $24.70 | 2019 | |
| Tonix Medicines, INC. | $24.30 | 2025 | Tonmya |
| Orthogenrx INC. | $14.85 | 2019 | |
| Si-Bone, INC. | $14.15 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.40 | 2023 | Seglentis |
| Vertical Pharmaceuticals, LLC | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sascha Qian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.